Aspirin could fight one of the most dangerous risks of COVID-19. Photo: www.heraldo.es
The patients with COVID-19 have a new hope, it is about using the aspirin to prevent one of the highest risks caused by coronavirus, Well this medicine which is generally used as a diluent for blood, since it has the possibility of reducing the probability that they begin to generate clots, avoiding further complications.
COVID-19: Could Aspirin Save Lives?
It will be the United Kingdom where the study will be carried out to find out if aspirin could really combat blood clots caused by COVID-19, will be in charge of scientists from RECOVERY (Randomized Evaluation of COVid-19 thERapY) that currently evaluates a range of potential treatments for the new coronavirus, in this regard, the co-lead investigator of the trial, stated:
“There are clear reasons to believe that (aspirin) could be beneficial, and it is safe, cheap, and widely available.”
RECOVERY on its website, notes that patients with COVID-19 It is more likely to generate clots because they have hyperreactive platelets, which serve to stop bleeding, and before this, aspirin works as an antiplatelet agent that could prevent this effect, saving the lives of many who are currently suffering with the new coronavirus.
Aspirin could prevent COVID-19 from forming clots in the blood of patients. Photo: elperiodico.com
The study It will be performed in 2,000 patients who will be randomly given 150 milligrams of aspirin a day together with the rest of their treatment, then the results will be compared with another 2,000 people who received treatment for COVID-19, but did not include said medicine.
It should be noted that aspirin It has several risks, because if it is taken for a long period of time it can damage the kidneys and increases the possibility of suffering internal bleeding, hence it is necessary that RECOVERY share the results of your study, to know in what dose it can be ingested and if it really is an effective treatment for patients with COVID-19, Meanwhile in The Truth News, we remind you to avoid self-medication.
YOU MAY BE INTERESTED: Did you know that ‘Aspirin’ and an Omega-3 reduce pre-cancerous intestinal polyps?
Notably RECOVERY, has also carried out studies with the Regeneron antibody cocktail, azithromycin antibiotic, remdesivir, dexamethasone and hydroxychloroquine, it is important to mention that the third of these medicines, is a steroid that has been shown to be good at fighting some of the symptoms of COVID-19.
With information from ambito.com
Source link by https://laverdadnoticias.com/estiloyvida/Aspirina-podria-ser-un-medicamento-para-combatir-el-COVID-19-20201107-0051.html
*The article has been translated based on the content of Source link by https://laverdadnoticias.com/estiloyvida/Aspirina-podria-ser-un-medicamento-para-combatir-el-COVID-19-20201107-0051.html
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!
These were the details of the news Could aspirin be a drug to fight COVID-19? for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at en24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
